These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 357836)

  • 1. [Coagulation and fibrinolytic system in the vascular risks diabetes mellitus and hyperlipoproteinemia (author's transl)].
    Zöller H
    Klin Wochenschr; 1978 Aug; 56(16):789-95. PubMed ID: 357836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Plasma fibrinogen activity in diabetes mellitus, hyperlipoproteinemia and hyperuricemia (author's transl)].
    Zöller H; Gross W
    MMW Munch Med Wochenschr; 1976 Apr; 118(16):493-4. PubMed ID: 178994
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Effect of hyperlipoproteinemia on blood fibrinolytic activity and thrombocyte aggregation].
    Kostić N; Secen S
    Med Pregl; 2000; 53(3-4):180-3. PubMed ID: 10965685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coagulation and fibrinolysis parameters in type 2 diabetic patients with and without diabetic vascular complications.
    Erem C; Hacihasanoğlu A; Celik S; Ovali E; Ersöz HO; Ukinç K; Deger O; Telatar M
    Med Princ Pract; 2005; 14(1):22-30. PubMed ID: 15608477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet adhesiveness, plasma fibrinogen, and fibrinolytic activity in juvenile-onset and maturity-onset diabetes mellitus.
    Sharma SC
    J Clin Pathol; 1981 May; 34(5):501-3. PubMed ID: 7053039
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Some alterations of blood coagulation, fibrinolysis and nail fold microcirculation in diabetes mellitus complications (author's transl)].
    Chi ZS
    Zhonghua Nei Ke Za Zhi; 1980 Apr; 19(4):247-51. PubMed ID: 7428516
    [No Abstract]   [Full Text] [Related]  

  • 7. [Some indices of the blood coagulation system and thrombus-formation in patients with diabetes mellitus].
    Ivanova NA
    Kardiologiia; 1971 Aug; 11(8):121-5. PubMed ID: 5160867
    [No Abstract]   [Full Text] [Related]  

  • 8. Fifteen coagulation and fibrinolysis parameters in diabetes mellitus and in patients with vasculopathy.
    Christe M; Fritschi J; Lämmle B; Tran TH; Marbet GA; Berger W; Duckert F
    Thromb Haemost; 1984 Oct; 52(2):138-43. PubMed ID: 6084321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The haemocoagulation system and macroangiopathy in insulin dependent (type I) diabetes.
    Fuller JH
    Ann Clin Res; 1984; 16(3):137-41. PubMed ID: 6236737
    [No Abstract]   [Full Text] [Related]  

  • 10. Swimming, but not vitamin E, ameliorates prothrombotic state and hypofibrinolysis in a rat model of nonalcoholic fatty liver disease.
    Sakr HF; Abbas AM; Haidara MA
    J Basic Clin Physiol Pharmacol; 2018 Jan; 29(1):61-71. PubMed ID: 29161233
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Role of blood clotting and fibrinolytic disorders in diabetics in the development of pathological changes in blood vessels].
    Chmielewski J
    Wiad Lek; 1973 Apr; 26(7):615-7. PubMed ID: 4573502
    [No Abstract]   [Full Text] [Related]  

  • 12. [Disorders of lipid content of blood in diabetes mellitus].
    Korotkova VD; Akhmetzianov AM; Masiakina LA; Doroguntseva IN; Mikhaĭlova EV
    Probl Endokrinol (Mosk); 1978; 24(1):9-13. PubMed ID: 204921
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Studies on the hemostatic system in young persons with primary hyperlipoproteinemia and after myocardial infarction. IV. Description of various parameters of the blood coagulation system, fibrinolysis and platelet aggregation using regression analysis].
    Borodin M; Chełstowski K; Torbus-Lisiecka B; Gregorczyk J
    Przegl Lek; 1986; 43(11):698-702. PubMed ID: 3575771
    [No Abstract]   [Full Text] [Related]  

  • 14. Variations and clinical significance of coagulation and fibrinolysis parameters in patients with diabetes mellitus.
    Hu J; Wei W; Din G; Yuan L; Liu Z
    J Tongji Med Univ; 1998; 18(4):233-5. PubMed ID: 10806853
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet aggregation and fibrinolytic activity in transient cerebral ischemia.
    Andersen LA; Gormsen J
    Acta Neurol Scand; 1977 Jan; 55(1):76-82. PubMed ID: 842281
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Resting levels of blood fibrinolysis in hyperlipoproteinemia.
    Brakman P; Astrup T; Levy RI; Fredrickson DS
    J Appl Physiol; 1974 Apr; 36(4):430-3. PubMed ID: 4274385
    [No Abstract]   [Full Text] [Related]  

  • 17. [Different forms of hyperlipoproteinemia in diabetics (author's transl)].
    Vogt N; Englhardt A
    Med Klin; 1975 Nov; 70(46):1871-7. PubMed ID: 171548
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blood coagulation and fibrinolysis in obese NIDDM patients.
    Avellone G; Di Garbo V; Cordova R; Rotolo G; Abruzzese G; Raneli G; De Simone R; Bompiani GD
    Diabetes Res; 1994; 25(2):85-92. PubMed ID: 7648783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipoprotein and fibrinogen studies in diabetes.
    Hart A; Cohen H; Thorp JM
    Postgrad Med J; 1971 Jun; 47():Suppl:435-9. PubMed ID: 5560136
    [No Abstract]   [Full Text] [Related]  

  • 20. [Contact (prekallikrein) and fibrinolytic (plasminogen/antiplasmin value) system in the physiopathology of vascular complications of diabetes].
    Janody D; Droulle C; Adjizian JC; Ostermann G; Poynard JP; Jeunehomme G; Leutenegger M; Potron G
    J Mal Vasc; 1982; 7(3):221-4. PubMed ID: 6815291
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.